A representation of Eli Lilly manufacturing facilities in Houston, Texas.
Courtesy: Eli Lilly
Eli Lilly On Tuesday, he said he will spend $ 6.5 billion to build a manufacturing installation in Houston, Texas, to boost the production of the company of the so -called small molecules drugs, including its experimental obesity pill closely.
It is the second of a series of new investments planned in the United States by the drug manufacturer. Eli Lilly announced in February that it would spend at least $ 27 billion to build four new national manufacturing plants, which adds to $ 23 billion in previous investments since 2020.
Eli Lilly said he will announce the two remaining American sites this year. The company expects to start medications in the four facilities in five years.
This aggregate production capacity for the Obesity pill of Eli Lilly, Orforglipron, is crucial since the company runs to take it to the market and tries to maintain its rise market domain for LPG-1. Eli Lilly and Novo Nordisk They have previously faced supply limitations with their existing weekly injections, as demand shot in the United States
“Our new Houston site will improve Lilly's ability to manufacture orforgripron on scale and, if approved, will help fulfill the potential of medicine as an obesity and a treatment of type 2 diabetes for dozens of millions of people worldwide who prefer the ease of a pill that can be taken without food and water restrictions,” said the CEO of Eli Lilly David Ricks in the Liberation
Drug manufacturers have been struggling to boost their production in the United States, since President Donald Trump threatens to impose tariffs on pharmaceutical products imported to the US. UU. Trump has said that these levies will encourage companies to return to production after the manufacture of domestic drugs was drastically reduced in the last decade.
In a statement on Tuesday, Eli Lilly said that the new Houston plant will focus on the manufacture of orforglipron and the company of the company of other small molecules medications in different areas of diseases, including cardiometabolic health, oncology, immunology and neuroscience. Small molecule medications, which often come in the form of a pill, are more convenient for patients to take that injectable medications and are generally easier and cheaper to manufacture at scale.
Eli Lilly said the site will bring 615 jobs to the Houston Metropolitan Area, including highly qualified, scientific engineers, operations and laboratory technicians, and 4,000 construction jobs.
